We have shown that the commonly used inhalant anesthetic isoflurane induces caspase activation and increases generation of Ab, the key component of senile plaques in Alzheimer's disease (AD) patients. Currently, it is not clear whether isoflurane, as well as other commonly used inhalant anesthetics, sevoflurane and desflurane, can induce these effects in vivo. This is an important question since increased A2 generation and caspase activation by anesthesia could conceivably serve to trigger or exacerbate the development of AD. Based on preliminary data, our central hypothesis is that isoflurane and sevoflurane, but not desflurane, can initiate a cascade of events that begins with caspase activation and results in the generation of Ab. The overarching goal of this proposal is to assess the potential role of routine general anesthesia as a risk factor for AD. The primary objective of this application is to determine the in vivo relevance of our previously observed in vitro effects of isoflurane, sevoflurane and desflurane on apoptosis and Ab generation.
In aim 1, we will systematically assess the effects of isoflurane, sevoflurane and desflurane on caspase activation, apoptosis, APP processing, and Ab generation in naove mice and, if necessary, AD transgenic mice. The mice will be treated with either isoflurane, sevoflurane, or desflurane, and potential effects on caspase activation, apoptosis, levels of full-length-APP, APP-C-terminal fragments and Ab, and levels and activities of BACE and 3-secretase will be determined. We will also explore the extent to which any or all of these effects can be reduced by caspase inhibitors, e.g., Z-VAD. If we are unable to measure endogenous A2 in naive mice, we will repeat these studies in AD transgenic mice, B6.Cg-Tg(APPswe, PSEN1dE9)85Dbo/J mice. In the second aim of this study, we will attempt to confirm our findings in normal human brain tissues harvested during temporal lobe resection from patients who have received isoflurane or desflurane anesthesia for surgical treatment of epilepsy, as it is not feasible to collect such data from normal human subjects. We will examine the effects of isoflurane and desflurane (but not sevoflurane as it can trigger seizure in epilepsy patients) on caspase activation, apoptosis, levels of full- length APP, APP C-terminal fragments and Ab, and levels and activities of BACE and gamma-secretase in patients who have received these inhalant anesthetics versus patients who have received non-inhalant anesthetics. The proposed research aims to provide in vivo relevance to our previous in vitro studies, and to offer new insight regarding the effects of isoflurane, sevoflurane and desflurane on caspase activation, apoptosis, APP processing and Ab generation in vivo. The data generated in this project should also provide some firm answers regarding the extent to which general anesthesia using isoflurane, sevoflurane or desflurane may initiate or accelerate the development of AD. The results of this study will ultimately guide clinicians with regard to how to provide the safest anesthesia care for patients, especially the elderly and those with AD.

Public Health Relevance

The proposed research will determine potential neurotoxic effects of inhalation anesthetics isoflurane, sevoflurane and desflurane in inducing cell death and increasing amyloid-b protein in mice and in humans. The results from the proposed studies will tell us whether or not isoflurane, sevoflurane and desflurane can increase the risk of Alzheimer's disease, and help us to develop safer anesthetics to provide better anesthesia care for patients, especially Alzheimer's disease patients and elderly patients.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AG029856-02
Application #
7683737
Study Section
Special Emphasis Panel (ZRG1-CND-E (90))
Program Officer
Refolo, Lorenzo
Project Start
2008-09-01
Project End
2012-02-29
Budget Start
2009-09-01
Budget End
2012-02-29
Support Year
2
Fiscal Year
2009
Total Cost
$186,013
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Xu, Zhipeng; Dong, Yuanlin; Wang, Hui et al. (2014) Peripheral surgical wounding and age-dependent neuroinflammation in mice. PLoS One 9:e96752
Xu, Zhipeng; Dong, Yuanlin; Wang, Hui et al. (2014) Age-dependent postoperative cognitive impairment and Alzheimer-related neuropathology in mice. Sci Rep 4:3766
Wang, H; Dong, Y; Zhang, J et al. (2014) Isoflurane induces endoplasmic reticulum stress and caspase activation through ryanodine receptors. Br J Anaesth 113:695-707
Ji, MuHuo; Dong, Lin; Jia, Min et al. (2014) Epigenetic enhancement of brain-derived neurotrophic factor signaling pathway improves cognitive impairments induced by isoflurane exposure in aged rats. Mol Neurobiol 50:937-44
Shao, Haijun; Zhang, Yiying; Dong, Yuanlin et al. (2014) Chronic treatment with anesthetic propofol improves cognitive function and attenuates caspase activation in both aged and Alzheimer's disease transgenic mice. J Alzheimers Dis 41:499-513
Zhang, Bin; Tian, Ming; Zheng, Hui et al. (2013) Effects of anesthetic isoflurane and desflurane on human cerebrospinal fluid A* and ýý level. Anesthesiology 119:52-60
Xie, Zhongcong (2013) Neuronal vulnerability to anesthesia neurotoxicity depends on age of neurons. Ann Neurol 73:686-7
Zhang, Y; Dong, Y; Zheng, H et al. (2013) Sevoflurane inhibits neurogenesis and the Wnt-catenin signaling pathway in mouse neural progenitor cells. Curr Mol Med 13:1446-54
Xie, Zhongcong; Xu, Zhipeng (2013) General anesthetics and ?-amyloid protein. Prog Neuropsychopharmacol Biol Psychiatry 47:140-6
Dong, Y; Wu, X; Zhang, G et al. (2013) Isoflurane facilitates synaptic NMDA receptor endocytosis in mice primary neurons. Curr Mol Med 13:488-98

Showing the most recent 10 out of 32 publications